There are 103 papers on syncope in aging research: 18 trials and 49 observational studies in people, 26 reviews.
21 new papers in 30 daysSee all 199 papers on syncope
“Three subjects experienced syncope, and one developed an anginal attack; ECG changes suggestive of coronary insufficiency were recorded.”
- Human trial18
- Humans49
- In silico2
Interventions
2GLP-1 receptor agonists
no changein humans2
2 studies
GLP-1 receptor agonists
no changein humans2
GLP-1 receptor agonists were not clearly linked with syncope in humans (patients with type 2 diabetes; compared with SGLT-2 inhibitors) (0.58% vs 0.56% 1-year absolute risk).
“The standardized 1-year absolute risk of syncope was 0.58% (95% CI: 0.51%-0.66%) among patients initiated on GLP-1 RA and comparable to patients initiated on SGLT-2i (0.56% [95% CI: 0.50%-0.62%]).”
Humanspatients with type 2 diabetes; compared with SGLT-2 inhibitors1 year
Vagal activity related events and glucagon-like peptide-1 receptor agonists
European heart journal. Cardiovascular pharmacotherapy
GLP-1 receptor agonists were not clearly linked with syncope in patients aged 65–84 years compared with < 65 years (ROR 0.96, 95% CI 0.83–1.12).
“unlike Syncope (ROR 0.96, 95% CI 0.83–1.12)”
Humansin patients aged 65–84 years compared with < 65 yearsn = 186,942
Research SquarePreprint
Atorvastatin
upin humans1
1 study
Atorvastatin
upin humans1
Atorvastatin induces syncope in humans after self-adjusting atorvastatin dose from 20 mg daily to 80 mg daily.
“We describe a 66-year-old man with hypertension and hyperlipidemia who developed syncope after self-adjusting atorvastatin from 20 mg daily to 80 mg daily for two weeks.”
Human trialafter self-adjusting atorvastatin dose from 20 mg daily to 80 mg daily80 mg dailytwo weeksmalesn = 1
Atorvastatin-Associated Severe Bradyarrhythmia Following Multiorgan Dysfunction: A Case Report
Clinical case reports
Associations
12Sudden cardiac arrest
upin humans1HR 1.29
1 study
Sudden cardiac arrest
upin humans1HR 1.29
Syncope is associated with sudden cardiac arrest in humans (Syncope within 5 years prior to health screening; adjusted for confounders) (Adjusted HR 1.29; 29% increased risk).
“the presence of syncope was associated with a 29% increased risk of developing SCA (HR, 1.29; p < 0.001).”
HumansSyncope within 5 years prior to health screening; adjusted for confoundersMean follow-up of 9.2 ± 1.3 years
Syncope as a predictor of sudden cardiac arrest: a nationwide population-based study
The Korean journal of internal medicine
Hematological phenotype
upin humans1HR 1.88
1 study
Hematological phenotype
upin humans1HR 1.88
Hematological phenotype predicts syncope in humans (HR = 1.88).
“syncope in Haematological women HR = 1.88, p = 0.009”
Humans~10-11 yearsfemales
Blood test patterns linked to health risks in older adults
npj aging
Fall risk
upin silico1
1 study
Fall risk
upin silico1
Syncope predicts fall risk in silico (acute conditions).
“short-term risk was driven by acute conditions like syncope, respiratory symptoms, and urinary tract infections”
In silicoacute conditionsshort-term
GeroScience
Fr-AGILE score
upin humans1OR 1.468
1 study
Fr-AGILE score
upin humans1OR 1.468
Fr-AGILE score is linked with a higher risk of syncope in humans (adjusted for age, sex, comorbidity, and number of medications) (OR 1.468, 95% CI 1.276–1.690, p = 0.001).
“frailty, estimated by the fr-AGILE score, was associated with an increased risk of syncope (OR for each unit increase in fr-AGILE: 1.468, 95% CI: 1.276–1.690, p = 0.001)”
Humansadjusted for age, sex, comorbidity, and number of medicationsn = 560
Syncope is associated with multidimensional frailty in older adults
BMC geriatrics
Heat stress
upin humans1
1 study
Heat stress
upin humans1
Heat stress raises the risk of syncope in humans (temperature of 120°C).
“A model was developed only for the temperature of 120°C because syncope had not occurred during the first sauna session with the temperature of 80°C.”
Human trialtemperature of 120°C26 minn = 3
Frontiers in public health
Orthostatic hypotension
upin humans1
1 study
Orthostatic hypotension
upin humans1
Orthostatic hypotension raises the risk of syncope in geriatric patients.
“Geriatric patients with OH are faced with an elevated risk of falls, syncope, a decline in their overall quality of life, and hence increased mortality.”
Reviewin geriatric patients
Cardiology in review
Mortality
upin humans1RR 1.05
1 study
Mortality
upin humans1RR 1.05
Syncope is linked with a higher risk of mortality in humans (patients with femur fracture) (RR 1.05, 95% CI 1.01-1.09).
“All-cause mortality was significantly higher among those with previous history of syncope compared to those without previous syncope (29.9% vs. 28.6%, P = 0.021).”
Humanspatients with femur fracturen = 93,093
Journal of geriatric cardiology : JGC
Pacemaker implantation
upin humans1RR 2.01
1 study
Pacemaker implantation
upin humans1RR 2.01
Syncope is linked with a higher risk of pacemaker implantation in humans (patients with femur fracture) (RR 2.01, 95% CI 1.55-2.46).
“significantly higher proportion of patients with syncope had a pacemaker implanted within one year (1.6% vs. 0.7%, P < 0.001; relative risk, 2.01 [95% CI: 1.55-2.46])”
Humanspatients with femur fracturen = 93,093
Journal of geriatric cardiology : JGC
Older age
upin humans1OR 1.01
1 study
Older age
upin humans1OR 1.01
Older age is associated with syncope in humans (COVID-19 patients at hospital admission) (0.7% versus 1.7%; OR 1.01, 95% CI 1.00–1.02).
“Older COVID-19 patients were more likely to present delirium, syncope and coma”
HumansCOVID-19 patients at hospital admissionn = 13,603
Neurological manifestations by sex and age group in COVID-19 inhospital patients
eNeurologicalSci
Incident fractures
upin humans1HR 1.2
1 study
Incident fractures
upin humans1HR 1.2
Syncope is linked with a higher risk of incident fractures in humans (compared with unaffected individuals) (HR 1.20; 95% CI 1.02-1.40; p = 0.025).
“Multivariable-adjusted Cox regression showed an increased risk of incident fractures following hospitalisations due to unexplained syncope (HR 1.20; 95% CI 1.02-1.40; p = 0.025)”
Humanscompared with unaffected individuals17.8 + 6.5 years
BMC medicine
Heat
upin humans1
1 study
Heat
upin humans1
Heat raises the risk of syncope in humans (sauna bathing) (3 syncope, 1 anginal attack).
“Three subjects experienced syncope, and one developed an anginal attack; ECG changes suggestive of coronary insufficiency were recorded.”
Human trialsauna bathing20 minn = 60
Effects of exposure to Finnish sauna
Israel journal of medical sciences
All 12Fewer
Trial sponsors
National Institute of Neurological Disorders and Stroke
1 trialPhase 250 people
1 trialPhase 220 people
Funding
1 grant since 2019Swiss National Science Foundation